The UNC CFAR is a consortium between three complementary institutions: The University of North Carolina at Chapel Hill, Research Triangle Institute, and Family Health International. This consortium represents one of the largest and most active groups of HIV/AIDS researchers in the country. The CFAR will support the breadth of HIV/AIDS-related research that characterizes the CFAR membership, spanning prevention, detection, and treatment. This support will be accomplished through the creation of six cores that will support critical approaches to controlling the HIV/AIDS epidemic: clinical research, behavioral research, research into mechanisms at the molecular level, and education outreach. The proposed cores are Administrative, Developmental, Clinical/Behavioral, Virology/Cancer, Pharmacology, and Biostatistics. Part of the Administrative Core will include an active outreach program through which the CFAR will play a visible role as a regional leader, a statewide role in education, and a facilitative role for new collaborative and translational research. The UNC CFAR will provide new and exciting opportunities for clinical research, and vaccine, drug and microbicide development. The UNC CFAR will aid in the understanding of the nature of drug resistance and the causes and treatment of AIDS-associated malignancies, and enhance the utilization of new collaborative efforts to understand the interplay between HIV, stress, drug abuse, and immune function and to elucidate the causes and potential treatment for HIV dementia.

National Institute of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-SCO-A (J1))
Program Officer
Nugent, Robert
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Internal Medicine/Medicine
Schools of Medicine
Chapel Hill
United States
Zip Code
Wohl, David A; Khan, Maria R; Tisdale, Caroline et al. (2011) Locating the places people meet new sexual partners in a southern US city to inform HIV/STI prevention and testing efforts. AIDS Behav 15:283-91
Cohen, Myron S; Gay, Cynthia L (2010) Treatment to prevent transmission of HIV-1. Clin Infect Dis 50 Suppl 3:S85-95
Anderson, Jeffrey A; Jiang, Hongyu; Ding, Xiao et al. (2008) Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection. AIDS Res Hum Retroviruses 24:685-94
Edwards, Lloyd J; Stewart, Paul W; MacDougall, James E et al. (2006) A method for fitting regression splines with varying polynomial order in the linear mixed model. Stat Med 25:513-27
Graham, Jinko; McNeney, Brad; Seillier-Moiseiwitsch, Francoise (2005) Stepwise detection of recombination breakpoints in sequence alignments. Bioinformatics 21:589-95
Esther Jr, Charles R; Henry, Marianna M; Molina, Paul L et al. (2005) Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatr Pulmonol 40:39-44
Meeker, Rick B; Boles, Jeramiah C; Robertson, Kevin R et al. (2005) Cerebrospinal fluid from human immunodeficiency virus--infected individuals facilitates neurotoxicity by suppressing intracellular calcium recovery. J Neurovirol 11:144-56
Baldewicz, Teri T; Leserman, Jane; Silva, Susan G et al. (2004) Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigation. AIDS Behav 8:345-55
Thorpe, Joshua M; Smith, Scott R; Trygstad, Troy K (2004) Trends in emergency department antibiotic prescribing for acute respiratory tract infections. Ann Pharmacother 38:928-35
Meeker, R B; Boles, J C; Bragg, D C et al. (2004) Development of neuronal sensitivity to toxins in cerebrospinal fluid from HIV-type 1-infected individuals. AIDS Res Hum Retroviruses 20:1072-86

Showing the most recent 10 out of 55 publications